A recent decision from the European Commission has highlighted the role of pricing algorithms and monitoring software in exacerbating the impact of an infringement of EU competition rules.
Why collaborative AI can become a legal minefield
The race is on to produce innovative AI-enabled products and services. Determining who owns or controls the IP rights of a new technology can get messy if contracts do not exist or do not contain clear IP terms
Artificial Intelligence and the future of work
AI’s impact on the workplace is contingent on many variables - the level of employees’ education and training, the cost of the technology, its adoption rate, regulation, ethics and how far AI creates new jobs.
How can AI apply to agriculture?
AI tools are being used to improve the entire food supply chain. This will become even more important as the world’s growing population creates an increasing demand for agricultural production.
British Prime Minister announces first AI and Data Grand Challenge
Theresa May has announced the first AI and Data grand challenge mission: to use data, AI and innovation to transform the prevention, early diagnosis and treatment of chronic diseases by 2030.
It’s still about the people: How technology and corporate culture shape each other
In most cases the rate of success for technology implementation is defined by the degree of compatibility between the technology and 'the way we do things around here'.
Artificial intelligence and the workplace in Germany
A fundamental digital shift affects all hierarchy levels in the working environment and therefore requires a critical review of roles, functions, hierarchies and values in the corporations.
AI and Insurance: Getting your house in order – planning for an intelligent future
The insurance industry is looking at the means to develop new business models that rely on the mining of large data sets in order to identify customers, price risk and analyse claims.
AI and Drug Development: The current landscape and IP considerations
AI has the potential to revolutionise the pharmaceuticals industry. Key considerations include how to monetise these innovations and what types of IP protection are available for AI-influenced drug discoveries?
Maximising the benefits of AI – supra-national considerations
A recent EC draft guidance document on a European approach to AI surveys the opportunities stemming from the use of AI for the European industry and the potential socio-economic impact of AI on EU citizens.